2 not yet recruiting. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Not yet recruiting 2 |
| Phase 2 | 2 | Not yet recruiting 2 |
Follow LM-364 for injection: new trials by email Literature Review of LM-364 for injection trials Research Report on LM-364 for injection
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I/II of LM-364 as a Single Agent or in Combination With Anti-tumor Therapy in Patients With Advanced Solid Tumors LM-364 for injection, Tislelizumab - Advanced Solid Tumor Cancer | Phase 1 / Phase 2 | Not yet recruiting | LaNova Medicines Limited | 90 | 2026-10-19 | 2026-10-14 |
| A Study of LM-364 as a Single Agent or in Combination With Anti-tumor Therapy in Patients With Advanced Solid Tumors LM-364 for injection, Tislelizumab - Malignant Tumors | Phase 1 / Phase 2 | Not yet recruiting | LaNova Medicines Limited | 90 | 2026-07-15 | 2026-07-10 |
Neoplasms (1)
Australia (1) · China (1)